Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Gynecol Obstet Hum Reprod ; 52(10): 102676, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37805076

ABSTRACT

Large loop excision of the transformation zone (LLETZ) of the uterine cervix is a surgical procedure very frequently performed. Simulation of LLETZ under colposcopic guidance has a major role in training practitioners. The objective was to present an ex vivo model of LLETZ.


Subject(s)
Trachelectomy , Uterine Cervical Dysplasia , Uterine Cervical Neoplasms , Female , Pregnancy , Humans , Uterine Cervical Dysplasia/surgery , Uterine Cervical Neoplasms/surgery , Colposcopy/methods , Cervix Uteri/surgery
2.
J Int Med Res ; 45(6): 1720-1730, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28703660

ABSTRACT

Objective To investigate the effect of anticoagulant treatment on pregnancy outcomes in patients with previous recurrent miscarriages (RM) who carry a methylenetetrahydrofolate reductase ( MTHFR) gene mutation. Methods In this longitudinal retrospective study, patients with RM were treated during pregnancy with either: (i) 100 mg/day aspirin and 5 mg/day folic acid (group 1); or the same protocol plus 0.4 mg/day enoxaparin (group 2). An age-matched group of triparous women without RM or thrombophilia was used as the control group (group 3). Results This study enrolled 246 women with RM (123 per treatment group) and age-matched controls ( n = 117). The delivery rate was significantly lower in group 1 than group 2 (46.3% versus 79.7%, respectively). The miscarriage rate was significantly lower in group 2 compared with group 1 (20.3% versus 51.2%, respectively). In the control group 3, the delivery rate was 86.3% and the miscarriage rate was 12.8%. Conclusion Treatment with low-dose aspirin, enoxaparin and folic acid was the most effective therapy in women with RM who carried a C677T MTHFR mutation.


Subject(s)
Abortion, Habitual/genetics , Abortion, Habitual/prevention & control , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Mutation/genetics , Abortion, Habitual/enzymology , Adult , Case-Control Studies , Female , Humans , Pregnancy , Pregnancy Outcome
3.
J Low Genit Tract Dis ; 21(2): 97-101, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28157826

ABSTRACT

OBJECTIVE: The aim of the study was to assess whether an age younger than 25 years at conization affected future pregnancy outcome as an independent factor. MATERIALS AND METHODS: A retrospective study of 115 women who underwent both loop electrosurgical excision procedure (LEEP) and subsequent pregnancy follow-up in a referral center was conducted. Two groups were considered: patients younger than 25 years at the time of LEEP (n = 42) and 25 years or older (n = 73). Analyzed data were occurrence of preterm adverse obstetrical event and, specifically, preterm labor (PL) and preterm rupture of membranes; stratification based on term of occurrence was performed: less than 37 weeks of amenorrhea (WA), less than 34 WA, and less than 26 WA. RESULTS: Patients characteristics were comparable in terms of excised specimen thickness and pathological analysis, as well as for tobacco intoxication during pregnancy. Although there was no difference of term at delivery or total number of preterm adverse obstetrical events, we found a significant increase of events (19% vs 4.1%) and PL (19% vs 0%) before 26 WA in the group of patients younger than 25 years. After adjusting for excised specimen thickness, the same results were found for thickness of 15 mm or less (respectively, 16.7% vs 3.3% and 16.7% vs 0%). For thickness of greater than 15 mm, only ratio of PL before 26 WA was higher in the group of patients younger than 25 years (33.3% vs 0%). CONCLUSIONS: Age younger than 25 years at the time of LEEP seems to be is associated with a more frequent occurrence of extremely early preterm adverse obstetrical events, particularly PL.


Subject(s)
Conization/adverse effects , Fetal Membranes, Premature Rupture/epidemiology , Obstetric Labor, Premature/epidemiology , Premature Birth/epidemiology , Uterine Cervical Dysplasia/therapy , Uterine Cervical Neoplasms/therapy , Adult , Age Factors , Case-Control Studies , Female , Humans , Pregnancy , Retrospective Studies , Uterine Cervical Neoplasms/diagnosis , Young Adult , Uterine Cervical Dysplasia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...